Pajzsmirigyrák: vizsgálatok itt: Norvégia
2 of 3 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Bergen, Oslo
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - No phaseTaking peoplePatient-centered Dosage of Levothyroxine
- Where
- Bergen, Oslo, Tromsø
- Életkor
- 18 év and over
- People
- 240
- Run by
- University Hospital of North Norway
See details and how to joinNCT06455371